Demis Hassabis raises $2.1 billion for Isomorphic Labs to accelerate AI drug discovery
By
Allie Garfinkle
Slow-proofed and worth the wait. Worth its weight in flour.
Summary
Demis Hassabis, CEO of Google DeepMind and Isomorphic Labs, discusses the company's new $2.1 billion Series B funding round led by Thrive Capital. The AI drug discovery startup aims to 'turbocharge' its next phase of development, with Hassabis working intensely (often until 4 AM) to advance AI-driven drug discovery and his ambitious goal of helping 'solve all disease.'
Key quotes
· 2 pulledWe're always running out of time, but that's something Demis Hassabis reckons with more than most.
Isomorphic raised a new $2.1 billion Series B, led by Thrive Capital, with the intention of 'turbocharging' its next phase.
You might also wanna read
Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery
This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google Deep
The Verge·11d ago
Demis Hassabis claims we're at the 'foothills of the singularity' as Google unveils Gemini for Science tools
Google DeepMind CEO Demis Hassabis closed Google I/O's keynote by suggesting we may be at the "foothills of the singularity," a hypothetical
The Verge·12d ago
Demis Hassabis emerges as key figure in Musk v. Altman trial testimony
During the Musk v. Altman trial, it has become evident that Demis Hassabis, CEO of Google DeepMind, was a constant presence in Elon Musk's t
The Verge·26d ago
Yann LeCun's AI Startup AMI Labs Raises Over $1 Billion in Record European Seed Round
Meta's former chief AI scientist Yann LeCun has launched a new AI startup called AMI Labs, which has raised over $1 billion in Europe's larg
ft.com·2mo ago
Anthropic raises $65B in Series H funding at $965B valuation
Anthropic has raised $65 billion in Series H funding led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital, achieving a $965 b
anthropic.com·3d ago